Behavorial Center At Girard is a licensed substance use treatment provider in Philadelphia, PA, listed in the SAMHSA treatment directory. It offers hospital inpatient care with medical staff on site around the clock. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adults
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
MedicaidState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentState department of healthHospital licensing authorityThe Joint CommissionDrug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
801 West Girard Avenue, Hawthorne Building, 4th Floor, Philadelphia, PA 19122
Hospital inpatient/24-hour hospital inpatientResidential/24-hour residentialHospital inpatient treatmentFederal, or any government funding for substance use treatment programsCash or self-payment
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare